Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells
- 1 June 2003
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 107 (3) , 198-201
- https://doi.org/10.1016/s1521-6616(03)00065-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cytokine dysregulation as a mechanism of graft versus host diseasePublished by Elsevier ,2004
- Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B CellsThe Journal of Immunology, 2002
- The Hematopoietic System–specific Minor Histocompatibility Antigen HA-1 Shows Aberrant Expression in Epithelial Cancer CellsThe Journal of Experimental Medicine, 2002
- Efficient cloning and expression of HLAclass I cDNA in human B-lymphoblastoidcell linesTissue Antigens, 2002
- Expression of minor histocompatibility antigen, HA-1, in solid tumor cellsTransplantation, 2002
- Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor EffectJournal of Clinical Oncology, 1999
- The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid PolymorphismScience, 1998
- Human minor histocompatibility antigensCurrent Opinion in Immunology, 1996
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine, 1993
- Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.Proceedings of the National Academy of Sciences, 1989